Macrophages control innate inflammation

Area of Science:

• Immunology
• Metabolic Diseases
• Cell Biology

Background:

• Macrophages are central to metabolic diseases like gout and type 2 diabetes.
• The NLRP3 inflammasome, involving ASC, drives macrophage-mediated inflammation.
• Trib1 regulates immune transcription factors and macrophage differentiation.

Purpose of the Study:

• To identify inhibitors of NLRP3 inflammasome activation.
• To elucidate the role of Trib1 in macrophage differentiation and metabolic homeostasis.

Main Methods:

• Compound screening to identify tubulin polymerization inhibitors.
• Investigating the effect of NLRP3 inflammasome inducers on NAD+ levels and Sirtuin 2 activity.
• Analyzing microtubule-dependent mitochondrial transport in inflammasome activation.
• Generating and studying mice lacking Trib1 in hematopoietic cells.

Main Results:

• Tubulin polymerization inhibitors suppress NLRP3 inflammasome activation.
• NLRP3 inflammasome activation leads to decreased NAD+ levels, Sirtuin 2 inactivation, and α-tubulin acetylation.
• Microtubule-driven mitochondrial transport is crucial for NLRP3 inflammasome assembly.
• Trib1 deficiency in hematopoietic cells causes lipodystrophy, hypertriglyceridemia, insulin resistance, and increased inflammation.
• Trib1 is vital for M2-like macrophage differentiation and adipose tissue maintenance.

Conclusions:

• Microtubule dynamics and mitochondrial transport are essential for NLRP3 inflammasome activation.
• Trib1 is a critical regulator of tissue-resident M2 macrophage differentiation, crucial for suppressing metabolic disorders.